POC Coagulation Testing Market to Surge USD 1953.42 million, with Excellent CAGR of 4.61% by 2029

The persuasive POC Coagulation Testing Market report is a total overview of the market that takes into account various aspects of product definition, market segmentation, and the existing merchant landscape. This industry report is comprehensive and encompasses a mixture of parameters of the market and Healthcare industry. Complete company profiles included in this report also highlights what are the recent developments, product launches, joint ventures, mergers and acquisitions are taking place by the several key players and brands that are driving the market. An all-inclusive POC Coagulation Testing Market research report in no doubt will help businesses for the informed and better decisions and in this manner managing marketing of goods and services.

Point-of-Care coagulation testing are used to determine how long it takes for clot formation to begin, the dynamics of clot formation, and the solidity and stability of clots over time. They allow for parallel measurements on a single blood sample after clotting is activated with a variety of agonists.

Data Bridge Market Research analyses that the point-of-care (POC) coagulation testing market which was USD 1,079.12 million in 2021, is expected to reach USD 1953.42 million by 2029, at a CAGR of 4.61% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-poc-coagulation-testing-market

Point-of-care coagulation testing (POCCT) allows clinicians to quickly assess a patient's coagulation status in real time. POCCT has several advantages over standard coagulation assays. As a result, there is growing interest in using POCCT in a wide range of clinical settings, including trauma, cardiac surgery, obstetrics, liver disease, and burns. POC coagulation testing allows for rapid clinical decisions in haematological interventions and, when used in conjunction with a proper transfusion algorithm, may reduce blood product usage and potentially complications associated with blood transfusion.

Some of the major players operating in the point-of-care (POC) coagulation testing market are:

Abbott (U.S.)
Danaher (U.S.)
Siemens (Germany)
Sysmex Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Horiba Ltd. (Japan)
Nihon Kohden Corporation (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)
Maccura Biotechnology Co. Ltd. (China)
Bio Group Medical System (Italy)
Genrui Biotech Co. Ltd. (China)
A&T Corporation (Japan)
Beijing Succeeder Technology Inc. (China)
Diagnostica Stago SAS (France)
Helena Laboratories Corporation (U.S.)
Hycel (Austria)

Global Point-of-Care (POC) Coagulation Testing Market Dynamics
Drivers

Significant consumption of anticoagulant drugs
Anticoagulant drugs, also known as blood thinners which helps to reduce the chances of atrial fibrillation-related heart strokes about 75%. The growing consumption of these drugs is driving the need for coagulation testing procedures to monitor blood clotting. This demand will lead to the expansion of the point-of-care (POC) coagulation testing market during the forecast period.

Automation in POC coagulation testing products
The growth of automated POC coagulation testing products is growing due to surging demand, automatic data uploading, and minimal human efforts. This has helped medical practitioners to perform rapid testing with minimal intervention. The automation in POC coagulation testing products is expected to have a positive impact on the overall market growth.

Table of Contents:

• Introduction
• Market Segmentation
• Executive Summary
• Premium Insights
• POC Coagulation Testing Market: Regulations
• Market Overview
• POC Coagulation Testing Market, By Type
• POC Coagulation Testing Market, By Application
• POC Coagulation Testing Market, By Route of Administration
• POC Coagulation Testing Market, End-Users
• POC Coagulation Testing Market, By Region
• POC Coagulation Testing Market: Company Landscape
• SWOT Analyses
• Company Profile
• Questionnaires
• Related Reports

Browse More Reports

https://markettreports.blogspot.com/2023/09/asia-pacific-melanoma-cancer.html

https://markettreports.blogspot.com/2023/09/asia-pacific-digital-therapeutic-dtx.html

https://markettreports.blogspot.com/2023/09/asia-pacific-ophthalmology-market-size.html

https://markettreports.blogspot.com/2023/09/middle-east-and-africa-surface.html

About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.